Medical errors are a major source of patient mortality and morbidity, and are estimated to result in more deaths annually in the United States than influenza, diabetes mellitus, and suicide combined.
Results: The best-performing WBIT detection algorithm we developed was based on a support vector machine and incorporated changes in test results between consecutive collections across 11 analytes. This algorithm achieved an area under the curve of 0.97 and considerably outperformed traditional single-analyte delta checks.

Conclusions: Machine learning-based multianalyte delta checks may offer a practical strategy to identify WBIT errors prior to test reporting and improve patient safety.
Medical errors are a major source of patient mortality and morbidity, and are estimated to result in more deaths annually in the United States than influenza, diabetes mellitus, and suicide combined. 1, 2 Errors related to clinical laboratory testing can occur during the preanalytic, analytic, and postanalytic phases of testing. Because laboratories usually manage the analytic phase of testing with safeguards including internal quality control, proficiency testing, improved specimen tracking, and sometimes automation, the pre-and postanalytic phases may be the most vulnerable to errors. For example, inappropriate test selection and incorrect test result interpretation are common and may lead to delayed or incorrect diagnoses and serious patient harm. [3] [4] [5] Likewise, other preanalytic laboratory testing errors, such as those related to improper specimen collection, transport, or processing, can also lead to erroneous test results and may unfortunately be somewhat common.
One concerning type of preanalytic error in laboratory medicine is the wrong blood in tube (WBIT) error. WBIT errors occur when a phlebotomy specimen collected from one patient is labeled as though it was collected from a different patient. These errors occur in cases of patient misidentification or, more commonly, specimen mislabeling, and may be common. 6, 7 For example, in one setting, Dzik et al 8 found that WBIT errors occurred in approximately one in 165 specimens. Identifying WBIT errors can be quite difficult, because a mislabeled specimen may appear indistinguishable from a correctly labeled one and will generally produce a set of test results that appear facially valid. Undetected WBIT errors can seriously compromise clinical care if the clinical care team bases diagnostic or treatment decisions on test results corresponding to the wrong patient. For example, a patient with renal impairment might inappropriately receive gadolinium contrast if the patient's reported creatinine was measured on a specimen collected from a different patient with normal renal function.
Laboratories and hospital systems should have standardized procedures to reduce WBIT errors, including the use of risk-reducing specimen collection procedures and appropriate phlebotomist training. For example, phlebotomists should confirm patient identity at the time of collection and label the specimen in the presence of the patient. However, given the complexities and time pressure of modern health care, and the involvement of human processes in specimen collection, some occurrence of WBIT errors is likely inevitable. The use of electronic systems that check concordance between the patient wristband and specimen label or that generate the label at the bedside should presumably reduce WBIT errors. However, use of these electronic systems is limited or nonexistent at some hospitals due to cost, logistical problems, and workflow constraints. Although only a very small proportion of specimens are presumably affected by WBIT errors, WBIT errors in aggregate may not be rare due to high test volume. For example, even if only one in 1,000 (0.1%) specimens were impacted by a WBIT error, a hospital testing a million specimens per year might report 1,000 sets of erroneous results every year.
Even with 100% compliance with best practice guidelines, total elimination of WBIT errors is likely impossible. Therefore, processes to reliably detect these errors before result reporting could be highly valuable. Indeed, laboratorians have long advocated for the use of delta checks in identifying WBIT errors. [9] [10] [11] [12] Delta checks compare the present value of an analyte to its previous reported values for the same patient. If the difference between the current and prior value exceeds a threshold set by the laboratory, the current result fails the delta check and is either not reported or reported with a flag. While delta checks often just consider the absolute change in a test result (ie, absolute value of the current result minus the prior result), laboratories can use variations on this basic delta check framework. 10 For example, delta checks can consider the "velocity" of change (absolute change divided by the time interval) or the relative change (change in proportion to the earlier result or in proportion to the lower result). 10, 11, 13 Likewise, delta check procedures will usually include a maximum "look-back" time and will not calculate the delta check if the time since the last result for the analyte exceeds the look-back threshold. 10 Many laboratory information systems natively support the electronic calculation of delta checks. While US laboratories commonly use delta checks in current practice, the specific delta check methods and procedures vary between laboratories. 10 Despite the potential of delta checks, recent publications suggested that traditional "univariate" delta checks (which only look at a single analyte) have poor discriminative power in distinguishing true WBIT errors from clinical changes in test results. 14, 15 Because WBIT errors are infrequent relative to the total number of specimens, a useful delta check would need to provide a high degree of both sensitivity and specificity to ensure a substantial portion of errors are detected at a positive predictive value high enough to be useful without incurring a large number of false positives.
Although traditional single-analyte delta checks may not be very useful in detection of WBIT errors, we hypothesized that machine learning-based "multianalyte" delta checks might be. We suspected that a multivariate machine learning-based model that could consider changes across multiple analytes in combination might be much better equipped than using a single test value to distinguish patterns representing physiologic change from those indicating WBIT errors. Likewise, because many common blood tests are ordered as panels, implementation of a multianalyte delta check seems feasible. To test this hypothesis that machine learning-based multianalyte delta checks could outperform traditional single-analyte ones, we simulated WBIT errors in silica and trained five machine learning-based models to identify them.
Materials and Methods
Setting and Data
This study used inpatient laboratory test results for clinical testing performed at the Massachusetts General Hospital, an approximately 900-bed tertiary care academic medical center in Boston, MA. Study procedures were approved by our hospital's institutional review board.
We extracted all relevant inpatient laboratory tests results from our Sunquest Laboratory Information System via a Datamart. The data were compiled as shown in ❚Figure 1A❚. As shown, we evaluated patient test collections meeting inclusion criteria (eg, collection and admission during the defined time period) for which all of the following 11 commonly tested analytes were measured or calculated: calcium, magnesium, plasma blood urea nitrogen (BUN), plasma creatinine, plasma glucose, phosphorous, anion gap, plasma chloride, plasma potassium, plasma bicarbonate, and plasma sodium. As shown in ❚Figure 1B❚, we linked and aligned the results from each patient collection to the results from the most recent prior collection (if any) for the same patient admission (defined as a unique medical record number/admit date combination). We excluded patient collections for which there were no prior complete collections (ie, collection with all 11 analytes) on the same admission, or where the most recent complete collection was more than 36 hours prior (check look-back period of 36 hours).
General Experimental Approach
As shown in ❚Figure 1C❚, we performed a series of repeated experimental "runs" and captured the performance of various prediction models after each run. As described in greater detail below, each run involved simulating a set of WBIT errors, training various models to detect the WBIT errors, and then evaluating each model's performance on a set of WBIT errors simulated within an independent set of test data. We performed 100 runs at each of three simulated WBIT error rates (described below) for 300 runs total.
We performed our simulations and analysis in the R statistical scripting language.
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WBIT Error Simulation
We simulated WBIT errors using procedures similar to those proposed in prior publications. 12, 14, 15 In particular, we randomly sampled patient collections within the dataset for introduction of a simulated WBIT error. For A ❚Figure 1❚ Datasets and methods overview. A, Data preparation and the number of cases meeting each inclusion criteria filter. Selected tests were calcium, magnesium, plasma blood urea nitrogen, plasma creatinine, plasma glucose, phosphorous, anion gap, plasma chloride, plasma potassium, plasma bicarbonate, and plasma sodium. The "patient admission" was the unique combinations of patient record number and admission date. The "patient collection" was the unique combinations of collect date/time and patient admission. "Complete collections" were collections with a reported result for each of the selected tests.
a Due to the data extraction approach used, any results collected more than 30 days prior to the start of month A or more than 30 days after the end of month A were excluded. Given that 30 days greatly exceeds a typical admission, few, if any, results should have been excluded based on this criterion.
b An analogous 30-day rule was applied to month B for the testing data. Months A and B were more than 60 days apart to ensure no overlap between training and testing data. c Only included patient admissions that had at least one of the 11 selected tests.
d Multiple results for the same analyte, patient, and collect time (to the minute) were treated as a single data point; these were rare.
the selected patient collection, we replaced the current test results with a set of test results taken from a randomly selected patient collection from a different patient in the dataset, as shown in Figure 1B . This type of mismatch should approximate many types of WBIT errors. We define patient collections on which a WBIT error was introduced as "error cases" and patient collections for which a WBIT error was not introduced as "control cases." For the purposes of model development and testing, we simulated errors at a rate of 10%, 25%, and 50% of specimens. Although these rates of WBIT errors were much higher than would be seen in real practice and were selected only to generate enough error cases, the underlying rate of WBIT errors should in theory not impact the B ❚Figure 1❚ (cont) B, Schematic of the approach used to simulate wrong blood in tube (WBIT) errors (data shown are hypothetical and not from patients).
sensitivity, specificity, or area under the receiver operating characteristic (ROC) curve (AUC) of the prediction models. Our WBIT error generation approach involved the random selection of a different patient collection across all patients as the replacement values, and we did not exclude the possibility of a replacement from the same patient. Probabilistically, almost all, if not all, replacements would be from a different patient, modeling typical WBIT errors.
Features
We constructed the following features to use in predicting WBIT errors:
1. Absolute change in test result: the absolute value of the prior result minus the current result 2. Absolute velocity: the absolute change in test result divided by the time between the current result and most recent prior result C ❚Figure 1❚ (cont) C, Steps used to train and test the models. This represents a single run. The process was repeated 300 times using three different WBIT error prevalence rates. Univariate analyses required no specific training and thus did not utilize training data. AUC, area under the curve.
Actual values of prior test results (not based on changes between results)
Logistic Regression
We trained logistic regression models in R using base generalized linear modeling functionality.
Support Vector Machines
Support vector machines (SVM) represent a powerful class of supervised machine learning models. When used for classification (eg, classifying cases as WBIT errors or not WBIT errors) SVMs algorithms use a kernel function to transform the features (eg, test results and deltas) into a higher-dimensional space and construct a hyperplane within this transformed feature space that best separates the two classes. SVMs have been extensively described in prior literature. 17 We trained support vector machine-based models in R using the e1071 package with default settings.
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Models
We constructed univariate and multivariate models as described and defined in ❚Table 1❚. As shown, we built univariate models using both the absolute difference in test results and the absolute velocity of the change in test results. We built multivariate models looking at the absolute difference, absolute velocity, and actual values. All multivariate models included all features for all analytes as predictors.
Calculation of AUC, Specificity, and Positive Predictive Value
We calculated the univariate AUC for the absolute change in test result and the test result velocity for each analyte, representing the discriminative power of a traditional single-analyte delta check. Univariate AUC corresponds to the area under a ROC curve that would be constructed by calculating the sensitivity and specificity of WBIT error predictions at various threshold values whereby all deltas exceeding the threshold (eg, an absolute change in sodium of 4 meq/L) would be classified as WBIT errors. Because univariate predictions involve no training, we only calculated univariate AUC on the testing dataset. Using a typical approach, we calculated the AUC for the logistic regression and SVM-based models on the training and test data by varying the predicted probability that the case is a WBIT error. AUC values were calculated in R by calculating the Wilcoxon W test statistic and then using standard calculations to transform it to the AUC. Values of specificity at 50% and 80% sensitivity were calculated by first finding a threshold cutoff for each absolute change (univariate models) or predicted probability of a WBIT error (multivariate models) that produced the desired sensitivity. For example, a change of 4 units between consecutive results for a hypothetical test might give a sensitivity of 80%. We then applied that threshold to test results that were not WBIT errors to estimate specificity. Because there was generally not a threshold cutoff providing a sensitivity of exactly 50% of 80%, the actual sensitivities corresponding to the threshold cutoffs used were only approximately 50% and 80% and thus the actual specificities should be treated as approximations. The ROC curves display linear interpolations of sensitivity and specificity values between various cutoffs and thus the specificity estimates shown in bar graphs or in the results text may not exactly match those shown in the ROC curves. Positive predictive values (PPVs) were calculated by applying three hypothetical WBIT error prevalence rates (0.5%, 1%, and 2.5%) along with estimated values of sensitivity and specificity to Bayes theorem. PPVs 
Results
The training data consisted of 10,799 patient collections from 2,369 patient admissions. The test data consisted of 9,839 patient collections from 2,486 patient admissions.
Machine Learning Models Outperform Single-Analyte Delta Checks
❚Figure 2A❚ shows AUC values describing the discriminative power of changes in individual analytes (ie, univariate delta checks) to distinguish correctly labeled specimens from those representing WBIT errors. As shown, BUN and creatinine were the most powerful individual analytes in identifying WBIT errors, both having AUC values of 0.84 (median across the 300 runs; interquartile range [IQR] = 0.83-0.84) when looking at the absolute difference in consecutive results. Velocity of change was less powerful than absolute difference across all analytes. In contrast to the univariate analysis, the best performing multivariate delta check model could identify WBIT errors with a high degree of accuracy, as shown in ❚Figure 2B❚. The best performing multivariate delta check model was based on a SVM and used the absolute changes in each of the 11 analytes as well as the prior values for each of the 11 analytes. This delta A B ❚Figure 2❚ Univariate delta check predictive power. A, Areas under the receiver operating characteristic curves (AUCs) for univariate delta checks and (B) machine learning-based multivariate delta checks. Bars represent the median across the 300 runs and error bars represent interquartile ranges. BUN, blood urea nitrogen; Reg, regression; SVM, support vector machines. check model had a median AUC of 0.97 (IQR 0.96-0.97) on testing data. A ROC curve comparing two univariate delta checks to two machine learning-based multivariate delta checks is shown in ❚Figure 3❚. The prevalence of WBIT errors in the training and testing data (across the three prevalence rates over which WBIT errors were simulated) had a minor impact on model AUC (numerical data not shown). Performance on multivariate models when applied to the training data was similar to that when applied to the test data ( Figure 2B ), suggesting that overfitting was minimal.
Performance Differences Impact Practical Utility
❚Figure 4❚ shows the specificity of each individual analyte and of three multivariate models at a sensitivity of 50% and a sensitivity of 80%. At a sensitivity of 80%, the best performing single analytes, BUN and creatinine, were only 66% and 74% specific, respectively. In contrast, the best performing multivariate model, an SVM including the absolute change and current values for each analyte as predictors, had a specificity of 96% at 80% sensitivity.
Delta check models will only be useful in clinical practice if they can achieve a sufficient PPV to avoid "alarm fatigue"; indeed, in a scenario where the clear majority of positive results are false positive, flagged results are likely to be ignored. Because WBIT errors are presumed to be quite infrequent, these differences in accuracy translate into very important differences in PPV. ❚Figure 5❚ shows the PPV at various hypothetical prevalence rates of WBIT errors and sensitivity cutoffs. For example, at a sensitivity of 80% and a hypothetical prevalence of 0.005, BUN (the best performing single analyte) had a PPV of only 7% compared to 35% for the best performing multivariate model. Likewise, at a WBIT error prevalence of 0.01 and sensitivity of 80%, the best performing multivariate ❚Figure 4❚ Model specificity. The specificity of both univariate (looking at absolute change) and multivariate delta checks is shown when applied at 50% and 80% sensitivity. Bars represent the median across the 300 runs and error bars represent interquartile ranges. BUN, blood urea nitrogen; Reg, regression; SVM, support vector machines. ❚Figure 3❚ Multivariate model predictive power. Shown are the areas under the receiver operating characteristic (ROC) curves for two multivariate delta checks models when applied to testing datasets. For comparison, ROC curves are also shown for univariate delta checks (absolute change) on the two best performing analytes. BUN, blood urea nitrogen; SVM, support vector machines.
model provided a PPV of 52% compared to 13% for the best performing univariate model.
Machine Learning Models Identify Occasional Anomalies in Real Patient Data
To assess the performance of a multianalyte delta check model when applied under conditions paralleling real clinical practice, we performed a final experiment in which we trained an SVM model (using "differences and values") on the training data that included simulated WBIT errors. We then applied this model to the test dataset without simulating WBIT errors in the test data (and thus the test dataset represented actual, unmodified clinical data). Using an SVM threshold corresponding to 80% sensitivity (based on the training data), we identified 217 patient collections failing the delta check, representing 2% of the 9,839 total patient collections evaluated. A pathology resident (M.W.R.) reviewed the electronic health record for A B ❚Figure 5❚ Positive predictive value of models. The positive predictive value (PPV) of both univariate and multivariate delta checks is shown given three possible values wrong blood in tube error prevalence rates (0.5%, 1%, and 2.5%). Results are shown when delta checks are applied at a specificity of 50% (A) and 80% (B). BUN, blood urea nitrogen; Reg, regression; SVM, support vector machines.
23 of these cases, including the 11 predicted to have the greatest likelihood of representing a WBIT error using the SMV. Based on chart review, at least several of the results appeared to possibly represent true WBIT errors, although in most of these 23 cases, clinical factors could explain a large change in results across one or more tests. For example, we identified patients on dialysis, patients who developed acute kidney injury, and patients who had undergone major surgery, all of which could explain substantial variations in results for the tests included. The apparently low PPV of this algorithm with respect to WBIT errors in our hospital's patient data, despite what we expect are moderately high levels of expected sensitivity and specificity (80% and 99%, respectively based on the simulation data), might suggest that the true prevalence of WBIT errors in the patient population is quite low (prevalence of WBIT errors would be on the order of one in 1,000, assuming a PPV of 10%). While we still consider this algorithm to have some utility in identifying potential WBIT errors, the chart review highlighted an additional and perhaps more useful application of this approach in identifying clinically significant changes across sets of test results.
Discussion
Here we demonstrate that machine learning-based multianalyte delta checks are likely to be much more powerful than univariate delta checks in identifying WBIT errors. Furthermore, we show the univariate delta checks are unlikely to be of practical value in identifying WBIT errors, at least on the commonly measured chemistry analytes included in this study, consistent with prior findings. 14, 15 For example, the best performing univariate delta check in our study would only achieve a PPV of 13% if the underlying prevalence of WBIT errors is 1% and the model is run at a sensitivity of 80%. This univariate check would thus be of little use in real clinical practice, because only about one in seven results flagged would represent a true positive. Alerts applied at insufficient PPVs are likely to be ignored by physicians and may lead to annoyance and alert fatigue. [19] [20] [21] In contrast, machine learning-based multianalyte delta checks may be much more useful in practice. For example, at a sensitivity of 80% and a prevalence of 1%, the best performing multivariate delta check achieved a PPV of 52%. While this is not ideal, this alert indicated an approximately one in two chance of a serious error, and may indicate the need for further or repeat testing. Certain regulatory policies (such as those promulgated by The Joint Commission) 22 that require laboratories to refuse tests with minor labeling errors (eg, only a single identifier) support the philosophy that it is usually much better to err on the side of recollecting a specimen unnecessarily than to risk providing erroneous results. In addition, identification of these errors may provide valuable data to clinical teams and trigger focused quality improvement initiatives aimed at reducing WBIT errors.
As future work, we plan to improve our multianalyte delta check approach to enhance clinical utility and translate it to clinical practice. For example, we plan to evaluate models or sets of models that can better accommodate missing data. The approach presented here requires all 11 analytes included in our models to be present, but various imputation techniques could allow us to adapt the approach to various subsets of analytes. Likewise, we could train separate models for each subset of the analytes. In addition, we plan to train models that include other analytes, such as routine hematology testing, as previous research on mean corpuscular volume and other CBC parameters have suggested that they may be of use in delta check-based WBIT error detection. 11, 15 Finally, we plan to explore models that incorporate nonlaboratory features such as patient diagnosis and demographics as predictors. These nonlaboratory predictors may allow the models to contextualize changes in test results for the patient's particular situation; for example, a model might learn that wide changes in creatinine are to be expected in dialysis patients and are thus not indicative of WBIT errors.
While typical laboratory information systems would not include "out of the box" functionality to implement the types of machine learning models we propose here, we plan to explore and anticipate identifying practical implementation strategies. For example, as logistic regression-based predictions can be easily coded as set of arithmetic and "if/then" operations, which are often supported as part of various rules or calculation modules within laboratory information or middleware systems, this functionality may be implemented using a laboratory information system. 23 External systems or middleware modules may be required to implement the SVM-based models into clinical practice.
To be sure, we are not the first authors to propose the idea of delta checks looking across multiple analytes. For example, as far back as 1982, Iizuka et al 12 proposed a "multivariate" delta check and demonstrated its potential to detect WBIT errors. However, their work was conducted prior to the advent of modern computing and machine learning, and their approach was based on an unsupervised linear discriminate analysis that essentially looked for changes in results that would be statistically unlikely in the absence of a WBIT error under the assumption that test result deltas follow a multivariate normal distribution. In contrast, our approach uses supervised machine learning to train an algorithm specifically to detect WBIT errors. Our results are not directly comparable to Iizuka et al 12 given both the significant differences in methodology and analytes included in the delta check. Rheem and Lee 24 suggested looking at multiple univariate delta checks to make a decision about whether the sample is likely to represent a WBIT error, but again do not base their approach on a multianalyte supervised machine learning model. Both Iizuka et al 12 and Rheem and Lee 24 consider analytes such as cholesterol in their models, which are not typically measured on multiple occasions during an inpatient hospitalization, potentially limiting the utility for use on an inpatient basis; in contrast, we confine our delta check to analytes that are commonly repeated multiple times throughout an inpatient hospitalization.
Our study is subject to several assumptions and limitations. A key assumption is that our method simulates WBIT with similar characteristics to WBIT errors that occur in practice. This assumption should be valid to a first approximation because WBIT errors result in test results from one patient being reported on a different patient, consistent with our simulation methodology. However, in practice, switches may not be truly random across patients; for example, patients sharing a room, floor, or collection location would be more likely to be switched and may presumably have more similar disease states (eg, two patients on an oncology floor vs a patient from oncology and a patient in labor and delivery), and therefore more likely to have similar test abnormalities than a random patient in the hospital (which would decrease the ability to detect WBIT errors). Nonetheless, given that we used commonly measured chemistry analytes that are measured in a wide range of medical service areas and patient conditions, we believe that our approach should reasonably approximate true WBIT errors. Likewise, our PPV calculations speculate a range of possible prevalence rates of WBIT errors. Although we included multiple prevalence rates to capture a range of possibilities, it is possible that some hospitals have true rates of WBIT errors outside the ranges we used. We also assume that the original dataset of reported results contains no WBIT errors; this is almost certainly not the case because WBIT errors are a reality of laboratory medicine. WBIT errors in our original dataset would in effect lead to error cases being mislabeled as control cases. These errors, when present in the training data, may lead to suboptimally trained models; however, we suspect this effect should be minimal, because the clear majority of control cases should still be labeled correctly. Such misclassifications may lead true-positive predictions to get misclassified as false-positive predictions, in turn causing us to underestimate the specificity and PPV of the models. Thus, actual model performance may be slightly better than that shown here.
